These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3052704)
1. Membranes and cancer chemotherapy. Burns CP Cancer Invest; 1988; 6(4):439-51. PubMed ID: 3052704 [No Abstract] [Full Text] [Related]
2. Glycemic agents associated with phospholipids (PL) and cholesterol (Chol) as growth inhibitors of implanted tumours. Altman RF; Spoladore LG Arch Geschwulstforsch; 1970; 35(3):207-16. PubMed ID: 5516972 [No Abstract] [Full Text] [Related]
3. Biological membranes and malignancy: an overview of pharmacological opportunities. Greig RG; Poste G Ann N Y Acad Sci; 1986; 488():430-7. PubMed ID: 3555258 [No Abstract] [Full Text] [Related]
4. Potentiation of bleomycin cytotoxicity by membrane-interacting drugs and increased calcium ions. Mizuno S; Ishida A Biochem Biophys Res Commun; 1982 Aug; 107(3):1021-7. PubMed ID: 6182878 [No Abstract] [Full Text] [Related]
5. Recent developments in cancer chemotherapy. Jewers K Prog Drug Res; 1981; 25():275-360. PubMed ID: 7031765 [No Abstract] [Full Text] [Related]
6. [New ways of the chemotherapy of cancer]. Schmidt CG Krebsarzt; 1969; 24(3):129-49. PubMed ID: 5809854 [No Abstract] [Full Text] [Related]
7. The cell membrane as a target for cancer chemotherapy. Grunicke HH Eur J Cancer; 1991; 27(3):281-4. PubMed ID: 1851026 [No Abstract] [Full Text] [Related]
10. Interaction of antitumor drugs with human erythrocyte ghost membranes and mastocytoma P815: a spin label study. Sinha BK; Chignell CF Biochem Biophys Res Commun; 1979 Feb; 86(4):1051-7. PubMed ID: 435309 [No Abstract] [Full Text] [Related]
11. Conceptual basis for use of chemotherapeutic agents and their pharmacology. Vietti TJ; Valeriote FA Pediatr Clin North Am; 1976 Feb; 23(1):67-92. PubMed ID: 176622 [No Abstract] [Full Text] [Related]
12. Changes produced by cobra venom cytotoxin on the morphology of Yoshida sarcoma cells. Patel TN; Braganca BM; Bellare RA Exp Cell Res; 1969 Oct; 57(2):289-97. PubMed ID: 4899848 [No Abstract] [Full Text] [Related]
13. Membrane interaction of an antitumor antibiotic, mithramycin, with anionic phospholipid vesicles. Majee S; Chakrabarti A Biochem Pharmacol; 1999 May; 57(9):981-7. PubMed ID: 10796068 [TBL] [Abstract][Full Text] [Related]
14. Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy? Gelibter AJ; Lonardi S; Di Segni S; Fontana A; Loupakis F; Cognetti F; Labianca R J Clin Oncol; 2006 Oct; 24(28):4668-9; author reply 4669. PubMed ID: 17008710 [No Abstract] [Full Text] [Related]
15. Blood and neoplastic diseases. A rational approach to the chemotherapy of human malignant disease. I. Crowther D Br Med J; 1974 Oct; 4(5937):156-9. PubMed ID: 4529038 [No Abstract] [Full Text] [Related]
16. [Result of antineoplastic agents screening: 7th report]. Gan To Kagaku Ryoho; 1998 Mar; 25 Suppl 2():147-392. PubMed ID: 9551093 [No Abstract] [Full Text] [Related]
17. Membranes and cancer therapy an overview. Berlin NI Adv Pathobiol; 1980; 7():387-95. PubMed ID: 6931482 [No Abstract] [Full Text] [Related]
18. [Phospholipid and cholesterol levels in the tumor cell plasma membranes with different sensitivity to doxorubicin]. Chekhun VF; Tryndiak VP; Todor IM; Mykhaĭlenko VM; Kondrychyn IH; Dovbeshko HI; Repnyts'ka OP; Kulyk HI Ukr Biokhim Zh (1999); 2003; 75(4):120-5. PubMed ID: 14681985 [TBL] [Abstract][Full Text] [Related]
20. The amphiphilic nature of saponins and their effects on artificial and biological membranes and potential consequences for red blood and cancer cells. Lorent JH; Quetin-Leclercq J; Mingeot-Leclercq MP Org Biomol Chem; 2014 Nov; 12(44):8803-22. PubMed ID: 25295776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]